Triomics YC Application

Winter 2021Active

Triomics went through Y Combinator in the Winter 2021 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch: Winter 2021
Industry: HealthcareHealthcare Services
Team size: 50
Status: Active
Launched: 2021

Founders

Sarim KhanFounder
Hrituraj SinghFounder

What Triomics does

Triomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like clinical trial matching, visit preparation, and quality reporting. We replace that manual work with task-driven AI agents embedded directly into clinical workflows, automatically processing medical records at scale and in real time. Our platform is trusted by 4 of the top 10 Best Hospitals for Cancer ranked by U.S. News, as well as several of the largest community oncology practices.

Triomics's YC application, reconstructed

Y Combinator application

Triomics, Winter 2021 batch. The real form questions, answered from public data.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Triomics

Describe what your company does in 50 characters or less.

AI Agents for Oncology EHRs

What is your company going to make? Please describe your product and what it does or will do.

We are building AI agents that automatically extract and process data from unstructured oncology patient records like clinical notes, pathology reports, genomic panels, and scanned documents. Our AI works directly in clinical workflows to help cancer care providers with tasks like clinical trial matching, visit prep, and quality reporting - replacing slow, manual review of records.

Where do you live now, and where would the company be based after YC?

We live and work in New York, NY, and post-YC, the company will remain based here.

Explain your decision regarding location.

New York is where we built the product and found our initial customers. The oncology ecosystem and healthcare providers we engage with are primarily on the East Coast, so staying here keeps us close to the complexity and challenges we solve.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

See full application

Frequently Asked Questions

Is this the real Triomics YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Triomics's public data (launch notes, founder backgrounds, product description). It shows how a company like Triomics would present itself to YC, not the text they submitted.